SG48704A1 - Improved amino acid solutions for treatment of peritoneal dialysis patients - Google Patents

Improved amino acid solutions for treatment of peritoneal dialysis patients

Info

Publication number
SG48704A1
SG48704A1 SG1995002051A SG1995002051A SG48704A1 SG 48704 A1 SG48704 A1 SG 48704A1 SG 1995002051 A SG1995002051 A SG 1995002051A SG 1995002051 A SG1995002051 A SG 1995002051A SG 48704 A1 SG48704 A1 SG 48704A1
Authority
SG
Singapore
Prior art keywords
amino acid
peritoneal dialysis
treatment
acid solutions
dialysis patients
Prior art date
Application number
SG1995002051A
Other languages
English (en)
Inventor
Leo Martis
Michael R Jones
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of SG48704A1 publication Critical patent/SG48704A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/14—Dialysis systems; Artificial kidneys; Blood oxygenators ; Reciprocating systems for treatment of body fluids, e.g. single needle systems for hemofiltration or pheresis
    • A61M1/28—Peritoneal dialysis ; Other peritoneal treatment, e.g. oxygenation
    • A61M1/287—Dialysates therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicinal Preparation (AREA)
SG1995002051A 1992-12-22 1993-12-10 Improved amino acid solutions for treatment of peritoneal dialysis patients SG48704A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99585592A 1992-12-22 1992-12-22

Publications (1)

Publication Number Publication Date
SG48704A1 true SG48704A1 (en) 1998-05-18

Family

ID=25542284

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1995002051A SG48704A1 (en) 1992-12-22 1993-12-10 Improved amino acid solutions for treatment of peritoneal dialysis patients

Country Status (14)

Country Link
US (3) US5670176A (da)
EP (1) EP0626845B1 (da)
JP (1) JP3483885B2 (da)
KR (1) KR100309972B1 (da)
AT (1) ATE226433T1 (da)
AU (1) AU678201B2 (da)
CA (1) CA2129998C (da)
DE (1) DE69332433T2 (da)
DK (1) DK0626845T3 (da)
ES (1) ES2185646T3 (da)
MX (1) MX9308002A (da)
NZ (1) NZ259242A (da)
SG (1) SG48704A1 (da)
WO (1) WO1994014430A1 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2723690B1 (fr) * 1994-08-17 1996-09-27 Seb Sa Appareil de chauffe pour aliments, en particulier pour la realisation de fritures, comportant une contre-cuve
JPH1171273A (ja) * 1997-08-29 1999-03-16 Terumo Corp 腹膜透析液
AU751556B2 (en) * 1998-01-05 2002-08-22 Johns Hopkins University, The Supplement for dialysis patients
EP0970699B1 (en) * 1998-07-07 2005-09-07 Terumo Kabushiki Kaisha Peritoneal dialysis solution
US7186420B2 (en) * 1999-04-26 2007-03-06 Edwards Lifesciences Corporation Multi-part substitution infusion fluids and matching anticoagulants
US8105258B2 (en) * 1999-04-26 2012-01-31 Baxter International Inc. Citrate anticoagulation system for extracorporeal blood treatments
US6743191B1 (en) 1999-04-26 2004-06-01 Edwards Lifesciences Ag Substitution infusion fluid and citrate anticoagulation
US6830692B1 (en) * 1999-09-20 2004-12-14 Degussa Ag Amino acid composition for hemodialysis
US6787039B2 (en) * 2001-01-26 2004-09-07 Degussa Ag Amino acid composition for hemodialysis
JP2002275059A (ja) * 2001-03-15 2002-09-25 Inst Of Physical & Chemical Res 腎機能障害改善用アミノ酸組成物
ITTO20020672A1 (it) * 2002-07-26 2004-01-26 Medestea Res And Production S Composizioni farmaceutiche contenenti cheto-acidi per somministrazione endoperitoneale
US20050148647A1 (en) * 2003-10-31 2005-07-07 Landry Donald W. Hemodialysis solutions and uses thereof
CN100417380C (zh) * 2005-12-14 2008-09-10 于力犁 透析液用氨基酸粉/液、其复合透析液粉/液及制备方法
US20090246248A1 (en) * 2008-03-27 2009-10-01 Affinergy Coating compositions having improved performance
CN102370640A (zh) * 2010-08-18 2012-03-14 俞黎黎 血液透析用复方氨基酸制剂及含复方氨基酸的血液透析用制剂
EP2489408A1 (de) 2011-01-13 2012-08-22 Michael Tchirikov Aminosäurezusammensetzung und deren Verwendung zur Behandlung von fetaler Wachstumsrestriktion (IUGR) und zur parenteralen Ernährung von extrem Frühgeborenen
CN105640947A (zh) * 2014-11-10 2016-06-08 天津金耀集团有限公司 碱性必需氨基酸乳酸盐腹膜透析液药物组合物
CN105560275A (zh) * 2014-11-10 2016-05-11 天津金耀集团有限公司 碱性低钙必需氨基酸腹膜透析液药物组合物
CN105640945A (zh) * 2014-11-10 2016-06-08 天津金耀集团有限公司 低钙必需氨基酸腹膜透析液药物组合物
CN105640946A (zh) * 2014-11-10 2016-06-08 天津金耀集团有限公司 氨基酸（15）乳酸盐腹膜透析液药物组合物
CN105640948A (zh) * 2014-11-10 2016-06-08 天津金耀集团有限公司 必需氨基酸乳酸盐腹膜透析液药物组合物
AU2015356587B2 (en) * 2014-12-04 2020-04-09 Professional Dietetics S.P.A. Aminoacid-based composition for fibroelastin recovery in dermal connective tissues
CN108777999A (zh) 2015-09-21 2018-11-09 小利兰·斯坦福大学理事会 癌症的营养治疗
US10342824B2 (en) 2017-07-17 2019-07-09 Dr. Marlowe's Weight Loss Institute, P.L.L.C. Supplement for treating side effects of medications which cause metabolic acidosis
CA3084319A1 (en) * 2017-12-11 2019-06-20 Filtricine, Inc. Compositions, methods, kits and systems for cancer treatment and metabolic intervention therapy

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58500563A (ja) * 1981-04-27 1983-04-14 バクスタ−、トラベノ−ル、ラボラトリ−ズ、インコ−ポレイテツド グルコ−ス、アミノ酸およびインシユリンを含む透析液
US4357343A (en) * 1981-06-26 1982-11-02 Baxter Travenol Laboratories, Inc. Nutritional composition for management of renal failure
CA1239586A (en) * 1984-10-02 1988-07-26 Dimitrios G. Oreopoulos Dialysis solution containing amino acids
DE3821043A1 (de) * 1988-06-22 1989-12-28 Fresenius Ag Dialysier- und spuel-loesung zur intraperitonealen verabreichung
DE3843289A1 (de) * 1988-12-22 1990-06-28 Diehl Gmbh & Co Treibspiegelmunition
ES2121941T3 (es) * 1992-02-04 1998-12-16 Baxter Int Soluciones de dialisis peritoneal y metodos utiles para reducir las lesiones y los efectos psicologicos negativos producidos por la peritonitis.
US5589197A (en) * 1993-10-04 1996-12-31 Baxter International, Inc. Low sodium peritoneal dialysis solution

Also Published As

Publication number Publication date
ATE226433T1 (de) 2002-11-15
US5698230A (en) 1997-12-16
JP3483885B2 (ja) 2004-01-06
MX9308002A (es) 1994-08-31
EP0626845B1 (en) 2002-10-23
NZ259242A (en) 1997-03-24
WO1994014430A1 (en) 1994-07-07
US5776503A (en) 1998-07-07
US5670176A (en) 1997-09-23
CA2129998C (en) 2006-07-11
DK0626845T3 (da) 2003-02-17
CA2129998A1 (en) 1994-07-07
DE69332433D1 (de) 2002-11-28
DE69332433T2 (de) 2003-08-14
JPH07504210A (ja) 1995-05-11
KR950700059A (ko) 1995-01-16
KR100309972B1 (ko) 2001-12-28
AU5748894A (en) 1994-07-19
ES2185646T3 (es) 2003-05-01
AU678201B2 (en) 1997-05-22
EP0626845A1 (en) 1994-12-07

Similar Documents

Publication Publication Date Title
CA2129998A1 (en) Improved amino acid solutions for treatment of peritoneal dialysis patients
PL309398A1 (en) Interferon containing therapeutic composition
ZA989385B (en) Methods for treating hypercoagulable states or acquired protein C deficiency.
GEP20002146B (en) Therapeutic Peptide Derivatives
GB9321061D0 (en) Analgestic agent and its use
GB9510037D0 (en) Improvements in or relating to organic compounds
PL310476A1 (en) Application of lamotrigin in treating neuro-aids diseases
AU2544197A (en) Photopheresis treatment of chronic hcv infections
GR3025047T3 (en) Product containing growth factor and glutamine and use of growth factor for the treatment of intestinal mucosa
NO940506L (da)
EP0951470A4 (en) METHOD AND PHARMACEUTICAL COMPOSITION FOR ADMINISTERING IRON TO PATIENTS ON HEMODIALYSIS OR PERITONEAL DIALYSIS
EP0344997A3 (en) Use of phytic acid or a salt thereof as an activator of hypoxic cells and a circulatory ameliorator
GR3030383T3 (en) Solution containing igf-1.
DE69327314D1 (de) Zusammensetzungen enthaltend Lipoprotein-Associated-Coagulation-Inhibitor (LACI) zur Herstellung eines Medikaments zur Behandlung von akuten oder chronischen Enzündungen
MY112593A (en) A storage stable water solution for infusion containing a thrombin inhibitor
Giordano et al. Amino acid losses during CAPD in children
MX9700967A (es) Uso terapeutico de acetazolamida para el tratamiento de edema cerebral.
RU95102346A (ru) Способ лечения дисциркуляторной энцефалопатии
JPS56128711A (en) Glucose-electrolyte preparation for high-calorie transfusion
AU7373196A (en) Combination of temozolomide and alpha-ifn for the treatment of advanced cancer
UA31672A (uk) Спосіб лікування хворих на сепсис
RU94026137A (ru) Способ лечения нейродермита
AU6133386A (en) Composition for preparing a medicament for topical treatment of paradentium diseases
UA28207A (uk) Спосіб лікування черепно-мозкової травми
JPS6466130A (en) High polymer carcinostatic enhancer